MCU Inhibitor Ruthenium Red Alleviates the Osteoclastogenesis and Ovariectomized Osteoporosis via Suppressing RANKL-Induced ROS Production and NFATc1 Activation through P38 MAPK Signaling Pathway.

Details

Language :

English

ISSN :

19420900

Database :

Complementary Index

Journal :

Oxidative Medicine & Cellular Longevity

Publication Type :

Academic Journal

Accession number :

159075521

Full Text :

https://doi.org/10.1155/2022/7727006